1. Second-line treatment in patients with advanced extra-pulmonary poorly differentiated neuroendocrine carcinoma: a systematic review and meta-analysis
   Mairéad G. McNamara et al, 2020, Therapeutic Advances in Medical Oncology CrossRef
2. Five Cases of Large-cell Neuroendocrine Carcinoma of the Lung Treated with Nivolumab
   Sayaka Kato et al, 2020, Haigan CrossRef
3. Management of Large Cell Neuroendocrine Carcinoma
   Virginia Corbett et al, 2021, Frontiers in Oncology CrossRef
4. MGMT promoter methylation and 1p/19q co-deletion of surgically resected pulmonary carcinoid and large-cell neuroendocrine carcinoma
   Lei Lei et al, 2018, World Journal of Surgical Oncology CrossRef
5. Managing Metastatic Extrapulmonary Neuroendocrine Carcinoma After First-Line Treatment
   Nikolaos Andreatos et al, 2023, Current Oncology Reports CrossRef
6. Large cell neuroendocrine carcinoma of the lung that responded to nivolumab: A case report
   Michiko Sato et al, 2020, Molecular and Clinical Oncology CrossRef
7. Case report of aggressive treatments for large-cell neuroendocrine carcinoma of the esophagus
   Yosuke Nakao et al, 2019, International Journal of Surgery Case Reports CrossRef
8. Efficacy of second-line chemotherapy in patients with pulmonary large cell neuroendocrine carcinoma
   Yuko Iida et al, 2024, Scientific Reports CrossRef